Table 2.
Short-Term (30 d) | Long-Term (3 y) | |||
---|---|---|---|---|
Frequency (%) | Event Rate | Frequency (%) | Event Rate | |
Recurrent VTE | ||||
eGFR< 30 | 8 (6.6) | 101.9 | 23 (18.9) | 15.9 |
eGFR=30-59 | 26 (6.0) | 84.9 | 57 (13.2) | 8.2 |
eGFR=60-89 | 24 (4.2) | 56.9 | 74 (12.9) | 7.5 |
eGFR ≥ 90 | 23 (6.1) | 81.0 | 60 (15.8) | 8.4 |
Major Bleeding Episodes | ||||
eGFR< 30 | 18 (14.8) | 246.3 | 30 (24.6) | 23.2 |
eGFR=30-59 | 29 (6.7) | 95.9 | 64 (14.8) | 9.1 |
eGFR=60-89 | 55 (9.6) | 136.9 | 71 (12.4) | 7.1 |
eGFR ≥ 90 | 21 (5.5) | 74.2 | 34 (9.0) | 4.6 |
All-Cause Mortality | ||||
eGFR< 30 | 28 (23.0) | 340.6 | 86 (70.5) | 52.5 |
eGFR=30-59 | 55 (12.7) | 170.4 | 206 (47.7) | 24.7 |
eGFR=60-89 | 59 (10.3) | 134.9 | 228 (39.7) | 19.0 |
eGFR ≥ 90 | 18 (4.7) | 60.1 | 111 (29.2) | 12.5 |
Note: event rates are shown per 100 person-years. eGFR given in mL/min/1.73 m2 (factor for conversion factor to ml/s/1.73 m2, ×0.01667).
Abbreviations: eGFR, estimated glomerular filtration rate; VTE, venous thromboembolism.